The vast majority of individuals with DS develop extracellular deposits of Aβ and intracellular accumulation of tau-containing NFTs by their mid-thirties to 40 years of age, which put this population at greater risk of early-onset AD [20, 135]. The gene discussed is MAPT; the disease is Alzheimer disease.